Stryker Corporation (LON:0R2S)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 92.71B -16.7% |
| Revenue (ttm) | 19.47B +8.5% |
| Net Income | 2.81B +27.8% |
| EPS | 7.27 +27.8% |
| Shares Out | n/a |
| PE Ratio | 32.99 |
| Forward PE | 20.44 |
| Dividend | 2.65 (1.08%) |
| Ex-Dividend Date | Sep 30, 2026 |
| Volume | 677 |
| Open | 327.58 |
| Previous Close | 333.24 |
| Day's Range | 317.22 - 340.00 |
| 52-Week Range | 281.04 - 396.86 |
| Beta | 0.77 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Stryker
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally inv... [Read more]
Financial Performance
In 2025, Stryker's revenue was $25.12 billion, an increase of 11.16% compared to the previous year's $22.60 billion. Earnings were $3.25 billion, an increase of 8.45%.
Financial numbers in USD Financial StatementsNews
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholder...
Stryker beats quarterly estimates on strong demand for medical devices
U.S. medical device maker Stryker on Thursday beat Wall Street estimates for second-quarter results, aided by strong demand for its implants and devices used in complex procedures ranging from spina...
Stryker Logs Higher Profit, Revenue Amid Cyberattack Recovery
The medical technology company reported a profit of $1.28 billion and and said it has made progress in recovering from a March cyberattack.
Stryker Earnings Call Transcript: Q2 2026
Second quarter results showed 9% organic sales growth and 17.9% adjusted EPS growth year-over-year, driven by strong demand, operational recovery post-cyber incident, and robust capital orders. Guidance for 2026 was narrowed, reflecting confidence in production ramp and backlog realization.
Stryker Earnings release: Q2 2026
Stryker released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Stryker Quarterly report: Q2 2026
Stryker has published its Q2 2026 quarterly earnings report on July 30, 2026.
Stryker reports second quarter 2026 operating results
Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026:
Stryker expands Mako robotics portfolio with full market release of Mako RPS
New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic market Stryker announced the U.S. commercial launch of M...
Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings
Booking Holdings, Alphabet, and six other companies have underperformed their sectors despite improving earnings expectations, setting up potential upside during second-quarter earnings season.
Buy these quality, low-stress stocks for the summer, says Jefferies
Markets have become more volatile as investors debate whether big tech companies are getting enough return on their AI spending. The S&P 500 momentum index has outperformed the wider market by more th...
Stryker to announce second quarter 2026 financial results
Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial result...
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
PORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane L...
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
PORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support perfo...
Stryker Launches Pangea Plating System and Completes First Case in Europe
AMSTERDAM--(BUSINESS WIRE)--Stryker announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.
BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem
CHARLEVOIX, Mich.--(BUSINESS WIRE)--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (A...
AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study
BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enroll...
Stryker Transcript: Bank of America Global Healthcare Conference 2026
Leadership reaffirmed commitment to innovation and M&A, with strong recovery plans after a cyber incident. Full-year guidance is maintained, supported by robust demand, operational resilience, and a healthy capital backlog. Mako robotics and new product launches drive growth.
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology com...
Stryker Transcript: AGM 2026
The meeting confirmed strong double-digit sales growth, major acquisitions, and a continued focus on innovation. All board nominees, auditor ratification, and executive compensation were approved. The five-year outlook projects sustained high growth through innovation and acquisitions.
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
Portage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at...
Stryker misses quarterly estimates on muted demand for medical devices
U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit and revenue, weighed down by softer demand for implants...
Stryker First-Quarter Sales, Profit Rise as it Dealt with Cyberattack
The medical-device company posted a profit of $745 million, up from $654 million in the same quarter a year ago.
Stryker Earnings Call Transcript: Q1 2026
Q1 2026 results were disrupted by a cyber incident, impacting sales and margins, but strong demand and operational recovery support reaffirmed full-year guidance for 8%-9.5% organic sales growth and $14.90-$15.10 adjusted EPS. M&A activity and new product launches are expected to drive growth.
Stryker Earnings release: Q1 2026
Stryker released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Stryker Quarterly report: Q1 2026
Stryker has published its Q1 2026 quarterly earnings report on April 30, 2026.